DUBLIN--(BUSINESS WIRE)--The "Type 1 Diabetes - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The report also includes total prevalent cases of T1D for all ages and both sexes. To forecast the diagnosed prevalent cases of T1D in the 8MM, epidemiologists selected nationally representative population-based studies that provided data for the diagnosed prevalence of T1D in the 8MM.
Type 1 Diabetes (T1D) Epidemiology Report provides an overview of the risk factors, comorbidities, and the global and historical trends for T1D in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada).
Additionally, the report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of T1D segmented by age (ages under 20 years, 20-29 years, 30-44 years, 45-59 years, 60-74 years, and 75 years and older), sex, body mass index (BMI), brittle (difficult-to-control) diabetes, experienced a diabetic ketoacidosis event, experienced hypoglycemia events, eligible for pancreas and/or islet transplantation, and require/will undergo a kidney transplant or have already received a kidney transplant.
Furthermore, research suggests that the incidence of T1D is increasing globally, which may lead to an increased burden on healthcare resources (Holt, 2004; World Health Organization, 2013; Mayo Clinic, 2020).
In the 8MM, the diagnosed prevalent cases of T1D will increase from 3,329,294 cases in 2019 to 3,921,695 cases in 2029, at an Annual Growth Rate (AGR) of 1.78% per year. Among the 8MM, the US had the highest number of diagnosed prevalent cases of T1D in 2019 and 2029, at 1,719,922 cases and 1,880,013 cases, respectively.
Canada had the lowest number of prevalent cases of T1D in 2019 and 2029, at 146,616 cases and 202,325 cases, respectively. Epidemiologists attribute the increase in the diagnosed prevalent cases of T1D in the 8MM to population changes as well as an increased trend in prevalence.
However, further research is necessary to clearly understand the epidemiological factors responsible for the growth in the prevalent cases of T1D (Onkamo et al., 1999).
Key Topics Covered:
1 Tables & Figures
2 T1D: Executive Summary
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.5 Epidemiological Forecast for T1D (2019-2029)
3.5.1 Diagnosed Prevalent Cases of T1D
3.5.2 Age-Specific Diagnosed Prevalent Cases of T1D
3.5.3 Sex-Specific Diagnosed Prevalent Cases of T1D
3.5.4 Diagnosed Prevalent Cases of T1D by BMI
3.5.5 Diagnosed Prevalent Cases of T1D with Brittle Diabetes and Diabetic Ketoacidosis Event
3.5.6 Diagnosed Prevalent Cases of T1D Who Have Experienced Hypoglycemia Events
3.5.7 T1D Diagnosed Patients Who Are Eligible for Pancreas and/or Islet Transplantation and Who Require/Will Undergo a Kidney Transplant OR Have Already Received a Kidney Transplant
3.5.8 Total Prevalent Cases of T1D
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 COVID-19 Impact
3.6.3 Limitations of the Analysis
3.6.4 Strengths of the Analysis
4 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/std5mm
